Agneta Wennerholm

Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype*

Karin Herrlin, Amos Massele, Mary Jande et al. · Clinical Pharmacology & Therapeutics · 1998 · 94 citations

The African‐specific <i>CYP2D6*17</i> allele encodes an enzyme with changed substrate specificity

Agneta Wennerholm, Collet Dandara, Jane Sayi et al. · Clinical Pharmacology & Therapeutics · 2001 · 91 citations

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

Rajaa A. Mirghani, Jane Sayi, Eleni Aklillu et al. · Pharmacogenetics and Genomics · 2006 · 86 citations

Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine

María Luisa Bernal, B. Sinués, Inger Johansson et al. · Pharmacogenetics · 1999 · 82 citations

Genetics, Human Polymorphism, Pathology +17

Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity

Agneta Wennerholm, Inger Johansson, Mats Hidestrand et al. · Pharmacogenetics · 2001 · 78 citations

Biology, Allelic Variant, Debrisoquine Metabolism +13